> Higher-than-expected demand for the mumps vaccine has caused a shortage in Japan, though the shortfall is expected to be alleviated between next week and the end of November. Story
> OncoQCR's breast cancer vaccine candidate, OQR200, induced high levels of antibodies and T-cell responses to HER2/neu cancer cells in a nonhuman primate study. Release